MediWound Ltd. (MDWD) vs Voyager Therapeutics, Inc. (VYGR)

MediWound Ltd. and Voyager Therapeutics, Inc. are both Biotechnology companies. MediWound Ltd. and Voyager Therapeutics, Inc. are of similar size ($178.6M and $172.5M). Voyager Therapeutics, Inc. grew revenue faster over the last twelve months: −19.1% against −40.3%. MediWound Ltd. has the higher net margin (−170.1% vs −312.6%) and the lower return on invested capital (−6,551.8% vs −192.6%). Across the 17 metrics below, Voyager Therapeutics, Inc. leads on 9 and MediWound Ltd. on 8.

Valuation

Metric MDWD VYGR Biotechnology median
P/E n/m n/m 7.88
P/S 15.04 4.71 11.47
P/B 5.01 1.05 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 12.14 1.33 10.73
Earnings yield (11.55%) (67.54%) (28.84%)
Free cash flow yield (16.01%) (74.83%) (23.03%)

Profitability

Metric MDWD VYGR Biotechnology median
Gross margin 15.46% 100.00% 65.16%
Operating margin (267.75%) (340.08%) 0.00%
Net margin (170.10%) (312.63%) 0.00%
Free cash flow margin (240.47%) (352.36%) 0.00%
Return on equity (75.42%) (54.09%) (57.72%)
Return on assets (29.06%) (41.45%) (49.22%)
Return on invested capital (6,551.77%) (192.55%) 0.00%

Growth

Metric MDWD VYGR Biotechnology median
Revenue growth (TTM) (40.26%) (19.07%) 5.64%
EPS growth (last fiscal year) 30.69% (80.53%) —
Revenue growth, 5-year CAGR (4.87%) (25.09%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD VYGR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 7.51 4.73
Net debt to EBITDA 2.27 1.50 0.96

Dividend

Metric MDWD VYGR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MDWD VYGR Biotechnology median
Market cap 178.55m 172.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack